EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma

Yu Yan, Zhenguo Liu, Dawei Zhou, Jiafeng Zou, Xinyu Liu iD

Cancer Biomarkers · 2026

DOI: 10.1177/18758592261479725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2026. Verfasst von Yu Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Kinesins, Cholesterol. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The heterogeneity of hepatocellular carcinoma (HCC) complicates diagnosis and treatment, and previous prognostic models have failed to yield satisfactory results. Given that the metabolic reprogramming of cholesterol plays a crucial role in the pathogenic mechanism of hepatocellular carcinoma, this study was conducted as a breakthrough point.

Methods

Utilizing multi-cohort data from TCGA, ICGC, and GEO, we screened Cholesterol metabolism-related genes (CMRGs) to construct a CMRG-derived prognostic model based on two key genes: KIF20A and NDC80 . Predictive performance was evaluated via Kaplan-Meier and ROC analyses. Additionally, the tumor immune microenvironment (TME) was characterized using CIBERSORT and ESTIMATE algorithms.

Results

The two-gene signature stratified patients into high- and low-risk groups, with high-risk patients showing poorer survival (HR = 2.71, P < 0.001). Elevated risk scores correlated with an immunosuppressive TME enriched in monocytes/macrophages. Exploratory anti-PD-1 analysis suggested higher risk scores were associated with non-response, warranting further validation.

Conclusion

The integrated nomogram achieved AUC values of 0.747 (95% CI: 0.665-0.830), 0.728 (95% CI: 0.652-0.804), and 0.778 (95% CI: 0.706-0.851) for 1-, 2-, and 3-year predictions. This KIF20A/NDC80-based model is a reliable prognostic tool for HCC; its immunotherapeutic utility remains exploratory and requires prospective validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsKinesinsCholesterolBiomarkers, TumorNuclear ProteinsHumansPrognosisImmunotherapyTumor MicroenvironmentNomograms

Stichwörter der Autor:innen

cholesterol metabolismhepatocellular carcinomaimmunotherapyprognostic signature

Substanzen

KinesinsCholesterolKIF20A protein, humanBiomarkers, TumorNuclear Proteins

Autor:innen und Institutionen

  • Department of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Xinyu Liu

Förderung

  • Natural Science Foundation of Hunan Province

Zitieren

APA

Yan, Y., Liu, Z., Zhou, D., Zou, J., & Liu, X. (2026). Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma. Cancer Biomarkers. https://doi.org/10.1177/18758592261479725

Vancouver

Yan Y, Liu Z, Zhou D, Zou J, Liu X. Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma. Cancer Biomarkers. 2026. doi:10.1177/18758592261479725

BibTeX
@article{Yan2026,
  author = {Yan, Yu and Liu, Zhenguo and Zhou, Dawei and Zou, Jiafeng and Liu, Xinyu},
  title = {Identification of a cholesterol metabolism-related signature based on KIF20A and NDC80 for prognostic stratification and immunotherapy prediction in hepatocellular carcinoma},
  journal = {Cancer Biomarkers},
  year = {2026},
  doi = {10.1177/18758592261479725}
}
Kostenlos starten →